Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-60.54%
operating margin TTM
-48.37%
revenue TTM
98.33 Million
revenue per share TTM
1.97$
valuation ratios | |
|---|---|
| pe ratio | -1.86 |
| peg ratio | -0.13 |
| price to book ratio | -10.88 |
| price to sales ratio | 1.13 |
| enterprise value multiple | -0.05 |
| price fair value | -10.88 |
profitability ratios | |
|---|---|
| gross profit margin | 63.36% |
| operating profit margin | -48.37% |
| pretax profit margin | -60.39% |
| net profit margin | -60.54% |
| return on assets | -30.52% |
| return on equity | -672.48% |
| return on capital employed | -601.55% |
liquidity ratios | |
|---|---|
| current ratio | 0.61 |
| quick ratio | 0.40 |
| cash ratio | 0.19 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 400.78 |
| operating cycle | 476.23 |
| days of payables outstanding | 180.47 |
| cash conversion cycle | 295.76 |
| receivables turnover | 4.84 |
| payables turnover | 2.02 |
| inventory turnover | 0.91 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.74 |
| debt equity ratio | -14.22 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 1.08 |
| interest coverage | -3.57 |
| cash flow to debt ratio | -0.23 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.43 |
| cash per share | 0.55 |
| operating cash flow per share | -0.39 |
| free cash flow operating cash flow ratio | 1.09 |
| cash flow coverage ratios | -0.23 |
| short term coverage ratios | -0.25 |
| capital expenditure coverage ratio | -11.58 |
Frequently Asked Questions
When was the last time Akoya Biosciences, Inc. (NASDAQ:AKYA) reported earnings?
Akoya Biosciences, Inc. (AKYA) published its most recent earnings results on 13-05-2025.
What is Akoya Biosciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Akoya Biosciences, Inc. (NASDAQ:AKYA)'s trailing twelve months ROE is -672.48%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Akoya Biosciences, Inc. (AKYA) currently has a ROA of -30.52%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AKYA's net profit margin stand at?
AKYA reported a profit margin of -60.54% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AKYA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.61 in the most recent quarter. The quick ratio stood at 0.40, with a Debt/Eq ratio of -14.22.